LADENBURG THALMANN FINANCIAL SERVICES INC. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 154 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 2.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2019$545,000
+15.5%
115,649
+4.8%
0.00%0.0%
Q3 2019$472,000
-26.6%
110,3510.0%0.00%
-40.0%
Q2 2019$643,000
+45.8%
110,351
-3.7%
0.01%
+66.7%
Q1 2019$441,000
+159.4%
114,540
+25.5%
0.00%
+50.0%
Q4 2018$170,000
-42.2%
91,247
-0.8%
0.00%0.0%
Q3 2018$294,000
+27.8%
91,988
+57.0%
0.00%0.0%
Q2 2018$230,0000.0%58,5920.0%0.00%0.0%
Q1 2018$230,000
-8.4%
58,592
-3.4%
0.00%0.0%
Q4 2017$251,000
+58.9%
60,635
+134.1%
0.00%0.0%
Q3 2017$158,000
+125.7%
25,896
+127.5%
0.00%
+100.0%
Q2 2017$70,000
+4.5%
11,383
+8.8%
0.00%0.0%
Q1 2017$67,000
+24.1%
10,459
+3.4%
0.00%0.0%
Q4 2016$54,000
-21.7%
10,111
-18.5%
0.00%0.0%
Q3 2016$69,000
+27.8%
12,409
+29.4%
0.00%0.0%
Q2 2016$54,000
-10.0%
9,593
+20.0%
0.00%0.0%
Q1 2016$60,000
+3.4%
7,993
+15.4%
0.00%0.0%
Q4 2015$58,000
-1.7%
6,929
+7.8%
0.00%0.0%
Q3 2015$59,000
-14.5%
6,429
+12.2%
0.00%0.0%
Q2 2015$69,000
+331.2%
5,729
+281.9%
0.00%
Q1 2015$16,000
-86.8%
1,500
-93.7%
0.00%
-100.0%
Q4 2014$121,00023,9000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2019
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders